0 of 5 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Currently, how confident are you in your ability to:
1 = not confident, 2 = somewhat confident, 3 = confident, 4 = very confident, 5 = extremely confident, N/A = not applicable to me
Develop personalized treatment plans for patients with dyslipidemia while incorporating PCSK9 inhibitor therapeutics?
Apply PCSK9 inhibitor therapeutics when treating patients with dyslipidemia?
Indicate how often you CURRENTLY use each the following clinical practice strategy for your patients with dyslipidemia.
*1 = Never, 2 = Not often, 3 = Sometimes, 4 = Often, 5 = Always, N/A = Not applicable to me
Utilize PCSK9 guidelines for treating patients with dyslipidemia.
1. The 2017 National Lipid Association Expert Panel had a PCSK9 inhibitor Recommendations chart that represented what a patient’s LDL cholesterol should be in order for the use of a PCSK9 inhibitor therapeutic to be “reasonable”. Which of the following represents the number that the LDL cholesterol for a patient with atherosclerotic cardiovascular disease and additional risk factors should be, in order for a PCSK9 inhibitor therapeutic to be reasonable?
2. According to a recent data set presented at the American College of Cardiology 2017, which of the following represents the percentage of filled PCSK9 inhibitor prescriptions that were abandoned at the pharmacy and never picked up?
3. True or False: Regarding PCSK9 inhibitors, if a patient is given a coupon for these therapeutics, they are 17 times more likely to receive the PCSK9 inhibitor.